313 related articles for article (PubMed ID: 9082363)
21. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
[TBL] [Abstract][Full Text] [Related]
22. Hyalinizing trabecular adenoma and papillary carcinoma of the thyroid gland express different cytokeratin patterns.
Hirokawa M; Carney JA; Ohtsuki Y
Am J Surg Pathol; 2000 Jun; 24(6):877-81. PubMed ID: 10843292
[TBL] [Abstract][Full Text] [Related]
23. Differential (Ha-, K- and N-) ras p21 expression in benign and malignant human thyroid tumors: an immunohistochemical study.
Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Nakamura S; Hashimoto T
Anticancer Res; 1995; 15(3):755-9. PubMed ID: 7645954
[TBL] [Abstract][Full Text] [Related]
24. Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases.
Puglisi F; Cesselli D; Damante G; Pellizzari L; Beltrami CA; Di Loreto C
Anticancer Res; 2000; 20(1A):311-6. PubMed ID: 10769673
[TBL] [Abstract][Full Text] [Related]
25. Serum cytokeratins determination in differentiated thyroid carcinoma.
Appetecchia M; Meçule A; Ducci M; Palma L; Castelli M
J Exp Clin Cancer Res; 2001 Jun; 20(2):253-6. PubMed ID: 11484983
[TBL] [Abstract][Full Text] [Related]
26. Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors.
Prasad ML; Pellegata NS; Huang Y; Nagaraja HN; de la Chapelle A; Kloos RT
Mod Pathol; 2005 Jan; 18(1):48-57. PubMed ID: 15272279
[TBL] [Abstract][Full Text] [Related]
27. Distribution of Leu-7 antigen (HNK-1) in thyroid tumors: its usefulness as a diagnostic marker for follicular and papillary carcinomas.
Ghali VS; Jimenez EJ; Garcia RL
Hum Pathol; 1992 Jan; 23(1):21-5. PubMed ID: 1371984
[TBL] [Abstract][Full Text] [Related]
28. Expression of cytokeratins and vimentin in epithelial cells of normal and pathologic thyroid tissue.
Henzen-Logmans SC; Mullink H; Ramaekers FC; Tadema T; Meijer CJ
Virchows Arch A Pathol Anat Histopathol; 1987; 410(4):347-54. PubMed ID: 2433835
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical demonstration of ceruloplasmin in follicular adenomas and thyroid carcinomas.
Tuccari G; Barresi G
Histopathology; 1987 Jul; 11(7):723-31. PubMed ID: 3623436
[TBL] [Abstract][Full Text] [Related]
30. Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules.
Beesley MF; McLaren KM
Histopathology; 2002 Sep; 41(3):236-43. PubMed ID: 12207785
[TBL] [Abstract][Full Text] [Related]
31. Polysialic acid of the neural cell adhesion molecule in the human thyroid: a marker for medullary thyroid carcinoma and primary C-cell hyperplasia. An immunohistochemical study on 79 thyroid lesions.
Komminoth P; Roth J; Saremaslani P; Matias-Guiu X; Wolfe HJ; Heitz PU
Am J Surg Pathol; 1994 Apr; 18(4):399-411. PubMed ID: 8141431
[TBL] [Abstract][Full Text] [Related]
32. Tight junctions in thyroid carcinogenesis: diverse expression of claudin-1, claudin-4, claudin-7 and occludin in thyroid neoplasms.
Tzelepi VN; Tsamandas AC; Vlotinou HD; Vagianos CE; Scopa CD
Mod Pathol; 2008 Jan; 21(1):22-30. PubMed ID: 17962811
[TBL] [Abstract][Full Text] [Related]
33. Unusual tumors of the thyroid gland.
Baloch ZW; LiVolsi VA
Endocrinol Metab Clin North Am; 2008 Jun; 37(2):297-310, vii. PubMed ID: 18502328
[TBL] [Abstract][Full Text] [Related]
34. Intermediate-filament expression in thyroid gland carcinomas.
Schröder S; Dockhorn-Dworniczak B; Kastendieck H; Böcker W; Franke WW
Virchows Arch A Pathol Anat Histopathol; 1986; 409(6):751-66. PubMed ID: 3094239
[TBL] [Abstract][Full Text] [Related]
35. Dipeptidyl aminopeptidase IV in the cytologic diagnosis of thyroid carcinoma.
González-Cámpora R; Galera-Ruiz D; Armas-Padrón JR; Otal-Salaverri C; Galera-Davidson H
Diagn Cytopathol; 1998 Jul; 19(1):4-8. PubMed ID: 9664176
[TBL] [Abstract][Full Text] [Related]
36. Cytokeratin subtypes in thyroid tumours: immunohistochemical study with emphasis on the follicular variant of papillary carcinoma.
Cameron BR; Berean KW
J Otolaryngol; 2003 Oct; 32(5):319-22. PubMed ID: 14974863
[TBL] [Abstract][Full Text] [Related]
37. Thyroid cytology and histology.
Oertel YC; Oertel JE
Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Dec; 14(4):541-57. PubMed ID: 11289734
[TBL] [Abstract][Full Text] [Related]
38. CD56 expression in benign and malignant thyroid lesions.
Muthusamy S; Azhar Sha S; Abdullah Suhaimi SN; Kassim N; Mahasin M; Mohd Saleh MF; Md Isa N
Malays J Pathol; 2018 Aug; 40(2):111-119. PubMed ID: 30173227
[TBL] [Abstract][Full Text] [Related]
39. Synchronous occurrence of anaplastic, follicular and papillary carcinomas with follicular adenoma in thyroid gland.
Ganguly R; Mitra S; Datta AK
Indian J Pathol Microbiol; 2010; 53(2):337-9. PubMed ID: 20551551
[TBL] [Abstract][Full Text] [Related]
40. Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours. Preferential reactivity with malignant tumours.
Miettinen M; Kärkkäinen P
Virchows Arch; 1996 Nov; 429(4-5):213-9. PubMed ID: 8972756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
